Marwan Azar is an Infectious Disease physician affiliated with Yale University. OpenAlex indexes 152 publications with 4,650 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Cedar St # S169
New Haven, CT 065191612
Telephone
203-785-3561Registry record last updated 24 May 2017.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Medical CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
87.4%First-generation cephalosporins43.7%Cephalexin100%Part D<11 patientsTetracycline-class Drug16.1%Doxycycline Hyclate100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
12.6%Proton pump inhibitor12.6%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The respiratory syncytial virus vaccines are here: Implications for solid organ transplantation
American Journal of Transplantation
2024 - Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation
Infectious Disease Clinics of North America
2023 - Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge
American Journal of Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”